Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Treatment and Antimicrobial Resistance in Children with Urinary Tract Infections.

Vazouras K, Velali K, Tassiou I, Anastasiou-Katsiardani A, Athanasopoulou K, Barbouni A, Jackson C, Folgori L, Zaoutis T, Basmaci R, Hsia Y.

J Glob Antimicrob Resist. 2019 Jun 25. pii: S2213-7165(19)30160-2. doi: 10.1016/j.jgar.2019.06.016. [Epub ahead of print]

PMID:
31252156
2.

A prospective study on the epidemiology and clinical significance of viral respiratory infections among pediatric oncology patients.

Vliora C, Papadakis V, Doganis D, Tourkantoni N, Paisiou A, Kottaridi C, Kourlamba G, Zaoutis T, Kosmidis H, Kattamis A, Polychronopoulou S, Goussetis E, Giannouli G, Syridou G, Priftis K, Papaevangelou V.

Pediatr Hematol Oncol. 2019 Apr;36(3):173-186. doi: 10.1080/08880018.2019.1613462. Epub 2019 Jun 19.

PMID:
31215284
3.

Education, decision support, feedback and a minor reward: a novel antimicrobial Stewardship intervention in a Swedish paediatric emergency setting.

Malmgren A, Biswanger K, Lundqvist A, Zaoutis T.

Infect Dis (Lond). 2019 May 15:1-11. doi: 10.1080/23744235.2019.1606933. [Epub ahead of print]

PMID:
31088317
4.

Authors' Response.

Puopolo KM, Benitz WE, Zaoutis TE.

Pediatrics. 2019 May;143(5). pii: e20190533B. doi: 10.1542/peds.2019-0533B. No abstract available.

PMID:
31040198
5.

Effects of an antimicrobial stewardship intervention on perioperative antibiotic prophylaxis in pediatrics.

Donà D, Luise D, La Pergola E, Montemezzo G, Frigo A, Lundin R, Zaoutis T, Gamba P, Giaquinto C.

Antimicrob Resist Infect Control. 2019 Jan 15;8:13. doi: 10.1186/s13756-019-0464-z. eCollection 2019.

6.

Attributable length of stay and cost for pediatric and neonatal central line-associated bloodstream infections in Greece.

Karagiannidou S, Zaoutis T, Maniadakis N, Papaevangelou V, Kourlaba G.

J Infect Public Health. 2019 May - Jun;12(3):372-379. doi: 10.1016/j.jiph.2018.12.004. Epub 2019 Jan 4.

7.

Diagnosis and Management of Pediatric Influenza in the Era of Rapid Diagnostics.

Kitt E, Drew RJ, Cunney R, Beekmann SE, Polgreen P, Butler K, Zaoutis T, Coffin SE.

J Pediatric Infect Dis Soc. 2018 Nov 22. doi: 10.1093/jpids/piy118. [Epub ahead of print]

PMID:
30476135
8.

Management of Neonates Born at ≤34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.

Puopolo KM, Benitz WE, Zaoutis TE; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES.

Pediatrics. 2018 Dec;142(6). pii: e20182896. doi: 10.1542/peds.2018-2896. Review.

PMID:
30455344
9.

Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.

Puopolo KM, Benitz WE, Zaoutis TE; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES.

Pediatrics. 2018 Dec;142(6). pii: e20182894. doi: 10.1542/peds.2018-2894. Review.

PMID:
30455342
10.

Posaconazole Administration in Hospitalized Children in the United States.

Lavigne S, Fisher BT, Ellis D, Zaoutis TE, Downes KJ.

J Pediatric Infect Dis Soc. 2018 Nov 16. doi: 10.1093/jpids/piy119. [Epub ahead of print]

PMID:
30445549
11.

Variation in Outpatient Antibiotic Dispensing for Respiratory Infections in Children by Clinician Specialty and Treatment Setting.

Agiro A, Gautam S, Wall E, Hackell J, Helm M, Barron J, Zaoutis T, Fleming-Dutra KE, Hicks LA, Rosenberg A.

Pediatr Infect Dis J. 2018 Dec;37(12):1248-1254. doi: 10.1097/INF.0000000000002004.

PMID:
30408006
12.

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Karandikar MV, Nemati K, Bilker WB, Zaoutis T, Han JH.

Open Forum Infect Dis. 2018 Sep 10;5(10):ofy222. doi: 10.1093/ofid/ofy222. eCollection 2018 Oct.

13.

Antibiotics and Cure Rates in Childhood Febrile Urinary Tract Infections in Clinical Trials: A Systematic Review and Meta-analysis.

Vazouras K, Basmaci R, Bielicki J, Folgori L, Zaoutis T, Sharland M, Hsia Y.

Drugs. 2018 Oct;78(15):1593-1604. doi: 10.1007/s40265-018-0988-1. Review.

14.

The use of echinocandins in hospitalized children in the United States.

Downes KJ, Ellis D, Lavigne S, Bryan M, Zaoutis TE, Fisher BT.

Med Mycol. 2018 Sep 28. doi: 10.1093/mmy/myy084. [Epub ahead of print]

PMID:
30265325
15.

Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now?

Pana ZD, Zaoutis T.

F1000Res. 2018 Aug 29;7. pii: F1000 Faculty Rev-1347. doi: 10.12688/f1000research.14822.1. eCollection 2018. Review.

16.

Surveillance for central-line-associated bloodstream infections: Accuracy of different sampling strategies.

Kourkouni E, Kourlaba G, Chorianopoulou E, Tsopela GC, Kopsidas I, Spyridaki I, Tsiodras S, Roilides E, Coffin S, Zaoutis TE; PHIG investigators.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1210-1215. doi: 10.1017/ice.2018.187. Epub 2018 Aug 29.

PMID:
30156182
17.

Epidemiology of infections and antimicrobial use in Greek Neonatal Units.

Gkentzi D, Kortsalioudaki C, Cailes BC, Zaoutis T, Kopsidas J, Tsolia M, Spyridis N, Siahanidou S, Sarafidis K, Heath PT, Dimitriou G; Neonatal Infection Surveillance Network in Greece.

Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F293-F297. doi: 10.1136/archdischild-2018-315024. Epub 2018 Jun 28.

PMID:
29954881
18.

Multifaceted but Invisible: Perceptions of the Value of a Pediatric Cognitive Specialty.

Szymczak JE, Lee G, Klieger SB, Woods C, Creech CB, Gilsdorf JR, Dennehy P, Zaoutis T.

Hosp Pediatr. 2018 Jul;8(7):385-393. doi: 10.1542/hpeds.2017-0240.

19.

Candidemia in children: Epidemiology, prevention and management.

Mantadakis E, Pana ZD, Zaoutis T.

Mycoses. 2018 Sep;61(9):614-622. doi: 10.1111/myc.12792. Epub 2018 May 31. Review.

PMID:
29762868
20.

The Impact of Clinical Pathways on Antibiotic Prescribing for Acute Otitis Media and Pharyngitis in the Emergency Department.

Dona D, Baraldi M, Brigadoi G, Lundin R, Perilongo G, Hamdy RF, Zaoutis T, Da Dalt L, Giaquinto C.

Pediatr Infect Dis J. 2018 Sep;37(9):901-907. doi: 10.1097/INF.0000000000001976.

PMID:
29561517
21.

Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia.

Donà D, Zingarella S, Gastaldi A, Lundin R, Perilongo G, Frigo AC, Hamdy RF, Zaoutis T, Da Dalt L, Giaquinto C.

PLoS One. 2018 Feb 28;13(2):e0193581. doi: 10.1371/journal.pone.0193581. eCollection 2018.

22.

Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections.

Gerber JS, Ross RK, Bryan M, Localio AR, Szymczak JE, Wasserman R, Barkman D, Odeniyi F, Conaboy K, Bell L, Zaoutis TE, Fiks AG.

JAMA. 2017 Dec 19;318(23):2325-2336. doi: 10.1001/jama.2017.18715.

23.

Urinary Tract Infection Antibiotic Trial Study Design: A Systematic Review.

Basmaci R, Vazouras K, Bielicki J, Folgori L, Hsia Y, Zaoutis T, Sharland M.

Pediatrics. 2017 Dec;140(6). pii: e20172209. doi: 10.1542/peds.2017-2209. Review.

24.

Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.

Saxena S, Gee J, Klieger S, Kajon A, Petersen H, Zaoutis T, Fisher B.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):219-225. doi: 10.1093/jpids/pix041.

PMID:
28992290
25.

Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.

Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE.

JAMA Pediatr. 2017 Dec 4;171(12):e173219. doi: 10.1001/jamapediatrics.2017.3219. Epub 2017 Dec 4.

26.

Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.

Chiotos K, Tamma PD, Flett KB, Naumann M, Karandikar MV, Bilker WB, Zaoutis T, Han JH.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01440-17. doi: 10.1128/AAC.01440-17. Print 2017 Dec.

27.

Epidemiology of Invasive Fungal Disease in Children.

Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S3-S11. doi: 10.1093/jpids/pix046. Review.

28.

Bone and Joint Infections.

Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, Girschick H, Hartwig N, Kaplan S, Lorrot M, Mantadakis E, Peltola H, Rojo P, Zaoutis T, LeMair A.

Pediatr Infect Dis J. 2017 Aug;36(8):788-799. doi: 10.1097/INF.0000000000001635. No abstract available.

PMID:
28708801
29.

Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.

Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B, Sung L.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):191-198. doi: 10.1093/jpids/pix030. Review.

30.

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.

Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L.

J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1. Review.

PMID:
28459614
31.

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.

Rattanaumpawan P, Nachamkin I, Bilker WB, Roy JA, Metlay JP, Zaoutis TE, Lautenbach E; CDC prevention epicenters program.

Ann Clin Microbiol Antimicrob. 2017 Apr 8;16(1):25. doi: 10.1186/s12941-017-0202-4.

32.

The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.

Anderson DJ, Jenkins TC, Evans SR, Harris AD, Weinstein RA, Tamma PD, Han JH, Banerjee R, Patel R, Zaoutis T, Lautenbach E; Stewardship and Infection Control Committeea of the Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2017 Mar 15;64(suppl_1):S36-S40. doi: 10.1093/cid/ciw830. Review.

33.

Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge.

Clock SA, Jia H, Patel S, Ferng YH, Alba L, Whittier S, DeLaMora P, Tabibi S, Perlman J, Paul D, Zaoutis T, Larson E, Saiman L.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e144-e148. doi: 10.1093/jpids/pix003.

34.

The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Zerr DM, Weissman SJ, Zhou C, Kronman MP, Adler AL, Berry JE, Rayar J, Myers J, Haaland WL, Burnham CD, Elward A, Newland J, Selvarangan R, Sullivan KV, Zaoutis T, Qin X.

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):366-375. doi: 10.1093/jpids/piw076.

35.

Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.

Das S, Adler AL, Miles-Jay A, Kronman MP, Qin X, Weissman SJ, Burnham CA, Elward A, Newland JG, Selvarangan R, Sullivan KV, Zaoutis T, Zerr DM.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02656-16. doi: 10.1128/AAC.02656-16. Print 2017 May.

36.

Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.

Handy LK, Bryan M, Gerber JS, Zaoutis T, Feemster KA.

Pediatrics. 2017 Apr;139(4). pii: e20162331. doi: 10.1542/peds.2016-2331. Epub 2017 Mar 7.

37.

Factors associated with persistent colonisation with methicillin-resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Nachamkin I, Coffin SE, Davis MF, Julian KG, Zaoutis TE, Metlay JP, Linkin DR, Tolomeo P, Wise JA, Bilker WB, Hu B, Lautenbach E; CDC PREVENTION EPICENTERS PROGRAM.

Epidemiol Infect. 2017 May;145(7):1409-1417. doi: 10.1017/S0950268817000012. Epub 2017 Feb 21.

PMID:
28219463
38.

Azithromycin Prophylaxis for Laboring Mothers.

Gerber JS, Zaoutis TE.

Pediatrics. 2017 Feb;139(2). pii: e20163643. doi: 10.1542/peds.2016-3643. No abstract available.

39.

A Computerized Sexual Health Survey Improves Testing for Sexually Transmitted Infection in a Pediatric Emergency Department.

Goyal MK, Fein JA, Badolato GM, Shea JA, Trent ME, Teach SJ, Zaoutis TE, Chamberlain JM.

J Pediatr. 2017 Apr;183:147-152.e1. doi: 10.1016/j.jpeds.2016.12.045. Epub 2017 Jan 10.

40.

Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Lehrnbecher T, Robinson PD, Fisher BT, Castagnola E, Groll AH, Steinbach WJ, Zaoutis TE, Negeri ZF, Beyene J, Phillips B, Sung L.

Clin Infect Dis. 2016 Nov 15;63(10):1340-1348. Epub 2016 Aug 27. Review.

41.

Antifungal stewardship considerations for adults and pediatrics.

Hamdy RF, Zaoutis TE, Seo SK.

Virulence. 2017 Aug 18;8(6):658-672. doi: 10.1080/21505594.2016.1226721. Epub 2016 Sep 2. Review.

42.

Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).

Chiotos K, Vendetti N, Zaoutis TE, Baddley J, Ostrosky-Zeichner L, Pappas P, Fisher BT.

J Antimicrob Chemother. 2016 Dec;71(12):3536-3539. Epub 2016 Jul 27.

43.

The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.

Cluzet VC, Gerber JS, Metlay JP, Nachamkin I, Zaoutis TE, Davis MF, Julian KG, Linkin DR, Coffin SE, Margolis DJ, Hollander JE, Bilker WB, Han X, Mistry RD, Gavin LJ, Tolomeo P, Wise JA, Wheeler MK, Hu B, Fishman NO, Royer D, Lautenbach E; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2016 Oct;37(10):1226-33. doi: 10.1017/ice.2016.138. Epub 2016 Jul 28.

PMID:
27465112
44.

Antibiotic prescribing and expenditures in outpatient adults in Greece, 2010 to 2013: evidence from real-world practice.

Kourlaba G, Gkrania-Klotsas E, Kourkouni E, Mavrogeorgos G, Zaoutis TE.

Euro Surveill. 2016 Jun 30;21(26). doi: 10.2807/1560-7917.ES.2016.21.26.30266.

45.

Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review.

Folgori L, Bielicki J, Ruiz B, Turner MA, Bradley JS, Benjamin DK Jr, Zaoutis TE, Lutsar I, Giaquinto C, Rossi P, Sharland M.

Lancet Infect Dis. 2016 Sep;16(9):e178-e189. doi: 10.1016/S1473-3099(16)00069-4. Epub 2016 Jun 30. Review.

PMID:
27375212
46.

Gram-Negative Bacilli in Infants Hospitalized in The Neonatal Intensive Care Unit.

Patel SJ, Green N, Clock SA, Paul DA, Perlman JM, Zaoutis T, Ferng YH, Alba L, Jia H, Larson EL, Saiman L.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):227-230. doi: 10.1093/jpids/piw032.

47.

T2Candida Provides Rapid and Accurate Species Identification in Pediatric Cases of Candidemia.

Hamula CL, Hughes K, Fisher BT, Zaoutis TE, Singh IR, Velegraki A.

Am J Clin Pathol. 2016 Jun;145(6):858-61. doi: 10.1093/ajcp/aqw063. Epub 2016 May 31.

PMID:
27247378
48.

Safety of Automatic End Dates for Antimicrobial Orders to Facilitate Stewardship.

Ross RK, Beus JM, Metjian TA, Localio AR, Shelov ED, Desai BR, O'Neill SP, Zaoutis TE, Gerber JS.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):974-8. doi: 10.1017/ice.2016.103. Epub 2016 May 13.

PMID:
27174362
49.

Administration of Palivizumab in the NICU.

Vendetti N, Gerber JS, Sammons JS, Fisher BT, Zaoutis TE, Coffin SE.

Hosp Pediatr. 2016 Jun;6(6):354-8. doi: 10.1542/hpeds.2015-0238. Epub 2016 May 10.

50.

Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.

Zerr DM, Miles-Jay A, Kronman MP, Zhou C, Adler AL, Haaland W, Weissman SJ, Elward A, Newland JG, Zaoutis T, Qin X.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4237-43. doi: 10.1128/AAC.00187-16. Print 2016 Jul.

Supplemental Content

Loading ...
Support Center